Slingshot members are tracking this corporate initiative:
Incyte (INCY) and Merck (MRK) Expand Collaboration Agreement Investigating Epacadostat + Keytruda in Solid Tumors and Blood Cancers
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Jan 09, 2017 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2019
Don’t see a project related to the strategic initiative you care about?
Related Keywords Collaboration Agreement, Expansion, Epacadostat, Keytruda, Solid Tumors, Blood Cancers, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Bladder Cancer, Squamous Cell Carcinoma